Severe Henoch-Schönlein purpura with infliximab for ulcerative colitis

Infliximab (IFX) is an anti-tumor necrosis factor chimeric antibody that is effective for treatment of autoimmune disorders such as Crohn’s disease and ulcerative colitis (UC). IFX is well tolerated with a low incidence of adverse effects such as infections, skin reactions, autoimmunity, and maligna...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: Song, Yang, Shi, Yan-Hong, He, Chong, Liu, Chang-Qin, Wang, Jun-Shan, Zhao, Yu-Jie, Guo, Yan-Min, Wu, Rui-Jin, Feng, Xiao-Yue, Liu, Zhan-Ju
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2015
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4438047/
https://ncbi.nlm.nih.gov/pubmed/26019477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i19.6082
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller